Editor’s note: These responses were edited lightly for clarity and brevity.
Paul Dambowy, MD. CMO of MNGI Digestive Health (Minneapolis): The most novel technique would be endoscopic mucosal stripping with cold snare of medium-to-large colon polyps. This has led to a significant decrease in complications such as post-polypectomy bleeding, post-polypectomy electrocoagulation syndrome and hospitalizations.
Kenneth Wang, MD. Director of Mayo Clinic’s Advanced Endoscopy Group and Esophageal Neoplasia Clinic (Rochester, Minn.): Endoscopic resection. The treatment of early GI cancers has totally changed with endoscopic resection being the preferred method. Endoscopic myotomy has also changed the landscape for treatment of achalasia, with surgical myotomy becoming less common.
Brian Dooreck, MD. Gastrointestinal Diagnostic Centers and the Memorial Healthcare System (Miami): As more and more patients are interested in stopping chronic medical therapy with proton pump inhibitors, endoscopic therapy for the treatment of gastroesophageal reflux disease is evolving. Patients are also looking for alternatives to traditional antireflux surgery. In my opinion, gastroenterologists need a better understanding of the therapeutic options, besides surgical intervention, to patients who cannot or do not wish to take chronic PPI medications for GERD.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.